Fund performance: San Francisco stresses diversity and reaps the rewardPerformance at IVP XII, Clarus Lifesciences II improves last yearByMark Boslet6 October 2014•2 mins readJavaScript is required to read this article. Please enable it in your browser and reload the page.FundraisingInvestorsManagersFundraisingInvestor PerformancePerformance